No Evidence for Production of Intrathecal Immunoglobulin G against Acinetobacter or Pseudomonas in Multiple Sclerosis

Publisher： Karger

E-ISSN： 1421-9913|53|1|27-31

ISSN： 0014-3022

Source： European Neurology, Vol.53, Iss.1, 2004-12, pp. : 27-31

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intrathecal Baclofen in Multiple Sclerosis

By  

European Neurology, Vol. 72, Iss. 1, 2014-09 ,pp. : 32-34

Karger

Access to resources Recommend Favorite

Combined Immunoglobulin and Azathioprine in Multiple Sclerosis

By  

European Neurology, Vol. 39, Iss. 3, 1998-04 ,pp. : 178-181

Karger

Access to resources Recommend Favorite

Effects of Mitoxantrone on Multiple Sclerosis Patients’ Lymphocyte Subpopulations and Production of Immunoglobulin, TNF-alpha and IL-10

By  

European Neurology, Vol. 49, Iss. 3, 2003-03 ,pp. : 137-141

Karger

Access to resources Recommend Favorite

Interferon Beta-1a and Intravenous Immunoglobulin Treatment for Multiple Sclerosis in Iran

By  

European Neurology, Vol. 52, Iss. 4, 2004-12 ,pp. : 202-206

Karger

Access to resources Recommend Favorite

Evidence-Based Medicine and Multiple Sclerosis: Figures and Stories

By  

Neuroepidemiology, Vol. 35, Iss. 2, 2010-06 ,pp. : 100-100

Karger

Access to resources Recommend Favorite